Health Insurance Review And Assessment Service Reports Findings In Ulcerative Colitis (The Comparative Risk Of Serious Adverse Events With Tofacitinib And TNF Inhibitors In Patients With Ulcerative Colitis: The Korean Experience As Revealed By ...): Digestive System Diseases And Conditions
2022 MAY 05-- By a News Reporter-Staff News Editor at South Korea Daily Report-- New research on Digestive System Diseases and Conditions- Ulcerative Colitis is the subject of a report. According to news reporting out of Wonju, South Korea, by NewsRx editors, research stated,“ Tofacitinib is an oral, small-molecule Janus kinase inhibitor approved in South Korea for...
Source: insurancenewsnet.com
